Eli Lilly releases new, cheaper form of weight loss drug
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly…
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March…
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange during morning trading on February 23, 2024 in New…
Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.SEBASTIEN BOZON | AFP | Getty ImagesNovo Nordisk and…
Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic
Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular…
These 4 anti-obesity drug stocks could soar, Berenberg says
The anti-obesity drug market is expected to remain in focus this year after a bumper 2023 for weight loss drugmakers…
Obesity drug Wegovy’s trial result could ‘open up’ health insurance access
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois,…
